Current perspectives on the development of non-biogenic amine-based antidepressants

This publication has 96 references indexed in Scilit:

• Can ‘differential display’ methodologies make an impact on biological psychiatry?
  International Journal of Neuropsychopharmacology, 2001
• Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies
  Biological Psychiatry, 2000
• β-blocker Binding to Human 5-HT1A Receptors in vivo and in vitro Implications for Antidepressant Therapy
  Neuropsychopharmacology, 2000
• The question of feedback at the somadendritic region and antidepressant drug action
  Brain Research Bulletin, 2000
• Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo.
  Psychopharmacology, 2000
• Does the Addition of Pindolol Accelerate the Response to Electroconvulsive Therapy in Patients with Major Depression? A Double-Blind, Placebo-Controlled Pilot Study
  Journal of Clinical Psychopharmacology, 2000
• SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression
  The Lancet, 2000
• Chronic antidepressant treatments increase cytochrome b mRNA levels in mouse cerebral cortex
  Journal of Molecular Neuroscience, 1997
• Preferential Potentiation of the Effects of Serotonin Uptake Inhibitors by 5‐HT_1A Receptor Antagonists in the Dorsal Raphe Pathway: Role of Somatodendritic Autoreceptors
  Journal of Neurochemistry, 1997
• (−)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine
  European Journal of Pharmacology, 1996